Volume : 09, Issue : 09, September – 2022
Title:
10.FORMULATION AND EVALUATION OF CONTROLLED DRUG DELIVERY SYSTEM CONTAINING ACARBOSE
Authors :
Tripathi Sanskrit, Patel Arun, Patel Shailendra
Abstract :
Oral controlled drug delivery systems refer to those products where in a release controlling technology is instigated which in turn modulates the release pattern of drug from the device into gastro intestinal tract. The tablets are coated with cellulose acetate polymer contain polyethylene glycol 400 and polyvinyl pyrrolidine K30 (20 %) as pore former in varying concentration, which is dissolved in acetone (60 %) solution. In EOP the delivery orifice had been drilled on the surface of the coated tablet by mechanical method. The stability determination recommended by ICH guidelines testing parameters were carried with designed formulation for the 12-month study reveals, the osmotic tablets were stable under the standard operational conditions. The post compression parameter like thickness, hardness, uniform drug content, in vitro release kinetics and average weight of tablets are comparable with standard reference of Acarbose. The in vitro release data of optimized formulation CP5 determined by USP type II dissolution apparatus shows 96.6 ± 0.15 % at 12 hr. The kinetic modelling of release data gives the information of release mechanism from osmotic pump was mainly by diffusion and osmosis.
Cite This Article:
Please cite this article in press Tripathi Sanskrit et al, Formulation And Evaluation Of Controlled Drug Delivery System Containing Acarbose., Indo Am. J. P. Sci, 2022; 09(9).
Number of Downloads : 10
References:
1. Remington- Essentials of pharmaceutics, Linda Feton and Ali R Rajabi- Sahboomi, Pharmaceutical press, Vol.-1, 2013, pp 623-631.
2. Novel drug delivery, Yie. W. Chien, CRC Press-Taylor and Francis group, 2014, 2nd Edn (revised): pp 18-21.
3. Kumar P, Singh S, Rajinikanth P S, and Mishra B, “An over new of osmotic pressure controlled Release oral formulation”, Journal of Pharmaceutical Research, 2006, Vol. 5(2), pp 34-45.
4. Remington- Essentials of pharmaceutics’, Linda Feton and Ali R Rajabi- Sahboomi, Pharmaceutical press, Vol.-1, 2013, pp 623-631.
5. Modern pharmaceuticals, Alexander T. Florence and Juergen Siepmann, Informa Healthcare, Vol.2, 5th Edn: pp 9-19.
6. Essentials of medical pharmacology’, K.D Tripathi, Jaypee brother’s medical publisher (P) Ltd, 2015; 6th Edn: pp 258-259.
7. Campbell LK, White JR, Campbell RK. Acarbose: its role in the treatment of diabetes mellitus. Ann Pharmacother. 1996 Nov;30(11):1255-1262.
8. Ahmed Abd-Elbary, Mina Ibrahim Tadros, and Ahmed Adel Alaa-Eldin, “Development and in vitro/in vivo evaluation of Etodolac controlled porosity osmotic pump tablets”, AAPS Pharm Sci Tech, 2011, Vol. 12(2), pp 485–495.
9. Pramod Kumar, Sanjay Singh, Brahmeshwar Mishra, “Development and biopharmaceutical evaluation of extended release formulation of Tramadol Hydrochloride based on osmotic technology”, Acta Pharm, 2009, Vol.59, pp 15– 30.
10. The theory and practice of industrial pharmacy’, Leon Lachman, Liberman H A and Kanig J L CBS publishers & distributors Pvt Ltd, 2013, 4th Edn: pp 458-545.
11. Melissa Maltais, Ricardo Vargas and Therese Di Paolo, “Development of a new formulation for direct compression of a natural product”, Journal of Pharmaceutical Technology & Drug Research, 2015; 4(2): pp 1-6.
12.Rashmin S Thakor, Falguni D Majmudar, Jayvadan K Patel, Ganesh C Rajput and Manish P Patel, “Development and evaluation of osmotic drug delivery system for Calcium channel blocker drug”, Scholars Research Library, 2010, Vol. 2(3), pp 43-51.
13. Melissa Maltais, Ricardo Vargas and Therese Di Paolo, “Development of a new formulation for direct compression of a natural product”, Journal of Pharmaceutical Technology & Drug Research, 2015; 4(2): pp 1-6.
14. Rashmin S Thakor, Falguni D Majmudar, Jayvadan K Patel, Ganesh C Rajput and Manish P Patel, “Development and evaluation of osmotic drug delivery system for Calcium channel blocker drug”, Scholars Research Library, 2010, Vol. 2(3), pp 43-51.
15. Rajan K. Verma, Aditya M. Kaushal and Sanjay Garg, “Development and evaluation of extended-release formulations of Isosorbide mononitrate based on osmotic technology”, International Journal of Pharmaceutics, 2003, 263, pp 9– 24.
16. ‘Aulton’s pharmaceutics- The design and manufacture of medicines’, Aulton M E Churchill Livingstone, Elsevier. In, 2011, 3th Edn: pp 347.
17 Basani Gavaskar, Subash Vijaya Kumar and Dilip Dodda, “Effect of tablet formulation variables on Tramadol HCl elementary osmotic pump tablet”, International journal of Contemporary Research and Review, 2010, Vol. 1(6), pp 1-4.
18 Kumar Guarve and G. D. Gupta, “Development and In Vitro Evaluation of osmotically controlled oral drug delivery system of Carvedilol (Research Article)”, International Journal of Pharmaceutical Sciences and Drug Research, 2009, Vol. 1(2), pp 80-82.
19 F. A. Ibrahim, F. A. Ali, S. M. Ahmed and M. M. Tolba, “Kinetic Determination of Acarbose and Miglitol in Bulk and Pharmaceutical Formulations Using Alkaline Potassium Permanganate”, International journal of Biomedical science, 2007, Vol. 3(1), pp 20-30.
20 Cooper and Gunn’s tutorial pharmacy’, S J Carter, CBS Publishers and distributors, 2004, 6th Edn: pp 225-229.
21 ‘Aulton’s Pharmaceutics- The design and manufacture of medicines’, Aulton M E, Churchill Livingstone, Elsevier. In, 2011, 3th Edn: pp 355-357.
22. Bentley’s text book of pharmaceutics- An adaptation’, Sanjay K. Jain and Vandana Soni, Reed Elseviers India Pvt Ltd, 2012, pp 329-342.
23. F. A. Ibrahim, F. A. Ali, S. M. Ahmed and M. M. Tolba, “Kinetic Determination of Acarbose and Miglitol in Bulk and Pharmaceutical Formulations Using Alkaline Potassium Permanganate”, International journal of Biomedical science, 2007, Vol. 3(1), pp 20-30.
24. Abhishek Kumar Jain and Chandra Prakash Jain, “Effect of super disintegrating agent and osmogens on Ciprofloxacin loaded naturally occurring biodegradable coated tablets for colon targeting”, International Journal of Pharmacy and Pharmaceutical Sciences, 2010, Vol. 2(4), pp 160-165.
25. ‘Martin’s Physical Pharmacy and Pharmaceutical Sciences Physical Chemical and Biopharmaceutical Principles in the Pharmaceutical Sciences’, Patrick J. Sinko and Yashveer Singh, Lippincott Williams & Wilkins, 2011, 6th Edn: pp 462-474.
26. Harnish Patel, Dr. Upendra Patel, Hiren Kadikar and Bhavin Bhimani, “Formulation and evaluation of controlled porosity osmotic pump tablets of Glimepiride”, International Journal of Drug Delivery, 2012, Vol. 4(1), pp 113- 124.
27. Patel Henal, Sudeendra Bhat R, Balamuralidhara V and Pramod Kumar T.M, “Comparison of Stability Testing Requirements of ICH with other International Regulatory Agencies”, Pharma Times, 2011, Vol. 43(9), pp 21-24.
28. Mothilal M, Damodharan N, Lakshmi K.S and Sharanya V.Baratharaj, “Formulation and in vitro evaluation of osmotic drug delivery system of Metoprolol succinate”, International Journal of Pharmacy and Pharmaceutical Sciences, 2010, 2(1), pp 64-68.
29. Ankur Rohilla and Shahjad Ali, “Alloxan Induced Diabetes-Mechanisms and Effects”, International Journal of Research in Pharmaceutical and Biomedical Sciences, 2012, Vol. 3(2), pp 819- 823.
30. Sanket Kohli and Prem N. Kumar, “Combined effect of Coccinia indica leaf extract with Acarbose in type II diabetes induced neuropathy in rats”, Journal of innovations in pharmaceuticals and biological sciences, Vol. 1(2), pp 77–87.
31. Nitiraj G. Ransinga, Rajesh B. Nawalea, Prashant K. Puranika, and Bhushan A. Patila, “Formulation and development of solid dispersion based osmotic system for Pioglitazone HCl”, Journal of Pharmacy Research, 2012, Vol.5(5), pp 2789- 2794.